Compare moats
Up to three covered companies, band by band. Every call is a curated editorial judgment, never a disclosed figure — and every band carries its cited basis.
| Inventec | Axcelis Technologies | |
|---|---|---|
| Moat rating | none The 2025 annual report (English version filed with TWSE on 2026-05-08) describes a large ODM without a protected return. Revenue rose 6.95% to over NT$691.1 billion; the company's March 2026 investor deck puts 2025 gross profit at 5.3% of revenue against 5.2% in 2024, and its 2Q26 deck (2026-08-19) shows gross margin down to 4.2% from 5.1% a year earlier as revenue rose 45%. One coded customer ("a") took 50% of 2025 net sales and a second ("b") 14%. The report warns that rivals' spending is raising "both technological thresholds and price competition", which "may compress gross margins and affect market share performance". Independent data agree: DigiTimes' 1H25 ranking (via Global SMT, 2025-07-24) moved Inventec from 10th to 12th among the top 20 EMS/ODM vendors as Huaqin and Wiwynn overtook it, and a DigiTimes analysis (2025-01-27) found its 2024 net-profit rank six places below its revenue rank and its net margin at 1.5% or less since 2018, with no clear sign of improvement. No moat is claimable. | narrow Axcelis's FY2025 10-K describes a protected but contested position. On the durable side, it says 'Axcelis and Applied Materials are the only ion implant system manufacturers with a full range of implant products'. About 3,400 Axcelis products are in use in 27 countries, and they feed an aftermarket business (CS&I) that earned $268.0 million, or 31.9% of 2025 revenue. The company holds 169 active U.S. patents and 356 active patents granted in other countries. On the limiting side, the risk factors say the ion implant segment 'includes one company with substantially greater financial, engineering, manufacturing, marketing and customer service and support resources', as well as 'several smaller companies that could provide innovative systems'. U.S. export controls 'exacerbate the risk that Chinese customers will change suppliers to non-U.S. vendors', while Kingstone Semiconductor and CETC 'continue to develop ion implanters for the Chinese domestic market'. 'None of our customers have entered into a long-term agreement requiring it to purchase our products.' Revenue fell to $839.0 million in 2025 from $1,017.9 million in 2024. A full-line position with a large installed base, against a better-resourced rival and new Chinese entrants, is a narrow moat. |
| Moat type | none The candidate sources are IP and customer programmes, and neither shows up in returns. The report cites more than 17,500 patents granted worldwide as of December 2025, a top-ten place in Taiwan for invention patent applications for more than 25 consecutive years, and a "Server Liquid Cooling Patents" TOP 5 listing by DIGITIMES, and says Inventec "has long led the industry in the patent layout of liquid-cooling thermal solutions for servers"; R&D was 2.07% of 2025 revenue. Customer ties are stable ("no significant changes in the main sales customers and their sales proportions" over two years), but one customer took 50% of 2025 net sales. DigiTimes' analyst wrote (2025-01-27) that Inventec, Pegatron, Compal and Wistron all began as computer-system makers whose component businesses and degree of vertical integration can hardly match those of Chinese makers. Real engineering capability, but the 4.2% 2Q26 gross margin shows no durable barrier. | intangibles ip The FY2025 10-K grounds the advantage in owned implant technology rather than contractual lock-in. Its Purion implanters share 'a common platform which enables a unique combination of implant purity, precision, and productivity', and its high energy systems use 'production-proven RF Linac high energy, spot beam technology'. System assembly and testing stays in-house 'due to the high degree of expertise and intellectual property associated with the process and design'. The company holds 169 active U.S. and 356 foreign patents, though it says it is not 'substantially dependent on any single patent or any group of patents'. The installed base supports aftermarket revenue but does not lock customers in: the risk factors say customers often train 'their own staff to maintain and service' equipment and buy parts that are not patent-protected from third parties. Switching costs are therefore the weaker candidate. |
| Leadership | behind A mid-table member of the industry's top 20, outside the leading group. DigiTimes' 1H25 top-20 EMS/ODM ranking (via Global SMT, 2025-07-24) places Inventec 12th at an estimated US$10.8 billion, down from 10th in 1H24 and 2H24, after "Huaqin and Wiwynn each overtook Inventec"; the same report names Foxconn, Quanta, Wistron and Wiwynn as the "primary beneficiaries" of generative AI, and DigiTimes' 2025 ranking (cnyes, 2026-02-02) expects AI server and rack orders to concentrate in Foxconn, Wistron and Quanta. In notebooks, market research cited in Pegatron's 2025 annual report puts Inventec fourth of the five Taiwanese ODMs it lists, at 13.5 million units, behind Quanta's 46.73 million. 1H26 revenue rose 37% (2Q26 deck), but no cited source shows it regaining rank or joining the leading group: behind rather than at parity. | fast follower The FY2025 10-K says 'In the market for ion implantation systems, we mainly compete against Applied Materials' and that the two 'are the only ion implant system manufacturers with a full range of implant products'. It claims Axcelis 'has been a market leader in high energy ion implanters for many years' and is 'a technology leader and supplier of choice' in power devices. But its risk factors say the implant segment includes 'one company with substantially greater' resources (unnamed there; Applied Materials is the main rival it names), and it lists 'Achieve market share leadership across all served markets' as a 2026 goal rather than a current fact. No third-party market-share source was fetched, so these are the company's own claims. Which of the two full-line suppliers has the larger overall share is not established by the sources read. Because the only basis for a shared lead is the company's own description, and that description treats share leadership as a goal not yet met, the band is held at fast_follower rather than co_leader. |
| Pricing power | weak Company investor decks show gross margin of 5.3% in 2025 and 5.2% in 2024 (2026-03-10), and 4.2% in 2Q26 against 5.1% in both 1Q26 and 2Q25, with 1H26 at 4.6% against 5.5% while revenue rose 37% (2026-08-19). The annual report warns of price competition that "may compress gross margins". DigiTimes (2025-01-27) counted Inventec among Taiwanese makers whose net margin had been 1.5% or less since 2018, with no clear sign of improvement. | moderate The FY2025 10-K reports gross margin of 44.9% in 2025 against 44.7% in 2024. That held steady while revenue fell from $1,017.9 million to $839.0 million, but its risk factors warn that 'if we must lower prices to remain competitive without commensurate cost of goods savings, our gross margin and profitability will be adversely affected'. They also say that if suppliers raise component costs, Axcelis 'may not be able to raise the price of our products to cover all or part of the increased cost'. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management reported a non-GAAP gross margin of 42.7% (the call states its income-statement measures are non-GAAP unless noted, so it is not directly comparable with the 10-K's GAAP figures), 'slightly below our outlook of 43%', citing CS&I mix and higher than anticipated services costs. |
| Summary | Inventec is a Taiwanese ODM whose 2025 annual report puts computer products at 99.07% of revenue: notebooks, gaming laptops and desktops on one side, servers, storage, switches and rack solutions on the other, plus small smart-device, automotive and 5G lines. Its 1Q26 investor deck (2026-05-12) shows servers at 46-50% of revenue, level with PCs, after 41-45% in each of 2Q25 to 4Q25. Revenue rose 6.95% in 2025 to over NT$691.1 billion and 45% year on year in 2Q26 to NT$269,857 million, but 2Q26 gross margin fell to 4.2% from 5.1%. Inventec claims a leading liquid-cooling patent position and long customer relationships, yet independent sources do not place it among the AI-server leaders: DigiTimes moved it from 10th to 12th in its 1H25 EMS/ODM ranking as Wiwynn and Huaqin passed it, names Foxconn, Quanta, Wistron and Wiwynn as generative AI's "primary beneficiaries", and expects 2026 AI server and rack orders to concentrate in Foxconn, Wistron and Quanta. In notebooks, market research cited in Pegatron's annual report puts it fourth of the five Taiwanese ODMs listed for 2025, at 13.5 million units. A sizeable, capable second-tier ODM with thin margins and no protected position. | Axcelis is an ion-implant specialist. The FY2025 10-K says implantation was 98.2% of 2025 revenue, sold as the Purion family of high energy, high current and medium current single-wafer implanters, the Ovation batch implanters, and aftermarket parts, upgrades and services. Its strongest ground is power devices. Axcelis calls itself 'a technology leader and supplier of choice in the implant-intensive power device segment', which made up 55% of the value of 2025 system shipments, and its Purion Power Series covers silicon carbide wafers. 2025 was a down year: revenue fell to $839.0 million from $1,017.9 million, systems backlog to $457.0 million from $645.8 million, and operating profit to $119.3 million from $210.8 million, while gross margin held at 44.9%. The 10-K names Applied Materials as the main rival and the only other full-range implant maker; other competitors include Sumitomo Heavy Industries Ion Technology, Nissin Ion Equipment, Advanced Ion Beam Technology and two Chinese developers. Among its 2026 goals the company lists 'Achieve market share leadership across all served markets', which it has not yet reached. On the Q2 2026 call (https://www.marketbeat.com/earnings/reports/2026-8-5-axcelis-technologies-inc-stock/), management said electric vehicles remain the number one driver of silicon carbide demand. It also said it expects its merger with Veeco, under which each Veeco share converts into 0.3575 Axcelis shares according to the 10-K, to close in the second half of 2026, pending approval in China. |
| Chain position | Contract designer-manufacturer of notebooks and servers for brand and cloud customers, selling into America, Europe and Asia; the annual report names Intel and AMD as CPU suppliers, AUO, BOE and INX for panels, and SK-Hynix, Samsung and Kioxia for SSDs. | A front-end wafer-fab equipment supplier to chipmakers, concentrated in Asia and in power devices. The FY2025 10-K says implanter shipments to Asian customers were 76.0% of 2025 system revenue, international sales 83.7% of total revenue, and the top ten customers 55.2% of net sales. It also says sales to Chinese customers are expected to remain significant under U.S. export-control licensing. |
| Products (share / barrier) |
|
|
| Long-horizon vote | -0.20 at weight 0.20 · swarm neutral Editorial prior, not backtested. | +0.06 at weight 0.20 · swarm bearish Editorial prior, not backtested. |